ClinicalTrials.gg
Drug

Monalizumab clinical trials

Also written IPH2201.

studies test it
21
open now
5
in phase 3
2
first study started
2011

How each study uses monalizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the monalizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Monalizumab
14

Development codes

IPH2201
10
NN-8765
1
NN8765-3658
1
humZ270
1
Anti-NKG2A
1

Studies by the year they started

21 studies that test it; most in 2015 (3)

Studies that test monalizumab, by start year
YearStudies
20111
20141
20153
20161
20172
20181
20192
20202
20212
20222
20232
20251
20261

Who runs them

Industry 8 · Other 13

Innate Pharma (4) · AstraZeneca (3) · Assistance Publique Hopitaux De Marseille (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · National Cancer Institute (NCI) (1) · The Netherlands Cancer Institute (1) · MedImmune LLC (1) · Canadian Cancer Trials Group (1)

Often tested with

Tested in the same studies.

Oleclumab (6) · Ceralasertib (1) · Savolitinib (1) · Afatinib (1) · Palbociclib (1) · Niraparib (1) · Ragifilimab (1) · Durvalumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test monalizumab, phase 3 first.

Studies

Open first, then newest update. How each study uses monalizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test monalizumab →

Given beside what is tested · 3 — monalizumab is usual care or a partner of the new treatment

Codes

What other systems call monalizumab · ClinicalTrials.gg INT001388

  • MeSH (NLM) C000709515monalizumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3ZXZ2V0588MONALIZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q27929456monalizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C120208MonalizumabOne source FDA
  • DrugBank DB12824One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.